Skip to main content

Table 4 Description of adverse events in each group.

From: Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial

  N minoxidil N placebo
Withdrawal from treatment 9 1 12 0
Withdrawal from treatment because of adverse events 9 1 12 0
Serious Adverse events* 9 1 12 1
Any adverse events 9 8 12 11
Hypertrichosis 9 5 12 0
  1. *: not related to the treatment (flat foot and strabism correction)